PDX Portal

Model Details

Patient Information for Model: HCI-018

Model Contact

Model: HCI-018
Model Contact: Alana Welm
Institution: HCI Breast PDX Program
Email: Alana.Welm@hci.utah.edu

Patient Information

Clinical Timeline

Color Keys:

Positive

Negative

N/A

Clinical Information at Collection

Clinical Biomarkers/Mutations at Collection

Pathology Information at Collection

Model Information for Model: HCI-018

Model Details - Initial Implantation of Patient Tissue

Biomarkers & Mutations

Model Details - Acceptable Conditions for Passaging

Mutations (Cancer Gene Census List)

Mutation data is currently not available.

CNV

There are no omics data for this model.

Histology Information for Model: HCI-018

There are no histology images for this model.

Metastasis Information for Model: HCI-018

Patient

PDX

Abdomen

Adrenal gland

Bone

Bone (de novo)

Bones

Brain

CTC

Chest

Chest wall

Contralateral Breast

Dura

Fallopian Tubes

Head

Kidney

LMD

Liver

Lung

Lymph node

Lymph nodes

Neck

None

Ovary

Pancreas

Pericardium

Peritoneal cavity

Peritoneum

Pleura

Pleural effusion

Shoulder

Skin

Spine

Spleen

Thoracic Spine

Thymus

medistinal and right hilar

Patient Treatment Information for Model: HCI-018

Event Id	Treatment	Treatment Setting	Age at Start	Age at End	Duration
11	Radiation Therapy	Neoadjuvant	47.16	47.25	33 days
12	Adriamycin/Cyclophosphamide, Paclitaxel	Neoadjuvant	47.33	47.5	62 days
13	Tamoxifen	Neoadjuvant	47.5	49.5	730 days
21	Letrozole	Neoadjuvant	49.67	58.67	3285 days
32	Faslodex	Neoadjuvant	58.75	58.91	58 days